GSK stock price forecast: £2,000 support key as GSK trades flat

Traders Union
All News
Financial News
GSK slides 0.37% today to GBX2012.56

Highlights

GSK trades below key short- and medium-term moving averages, reflecting ongoing downside pressure from sellers.
Daily momentum and oscillators indicate oversold conditions, with short-term pessimism dominating recent price action.
GSK is expected to fluctuate between GBX 1,950 and GBX 2,070 over the next five days, with bull signals on weekly timeframes suggesting high rebound probability.

Oversold signals and weak momentum as sellers pressure price below resistance

GSK has slipped below the SMA-20 (GBX 2,109.70) and SMA-50 (GBX 2,105.48), while staying well above the SMA-200 (GBX 1,775.33). The Ichimoku Kijun line at GBX 2,054.14 currently acts as immediate resistance. On the daily chart, MACD is neutral and ADX (15.74) signals a weak trend. RSI (38.98), Stoch RSI (0.00), and CCI (–126.17) point to oversold conditions, and BBP is deeply negative, indicating seller dominance. Price action hovers at the lower end of the daily range (GBX 2,005.00 – 2,021.00) with moderate volatility and continued pressure after the open.

Sideways rebound favored as oversold conditions moderate

In the short term, GSK is projected to trade within a typical volatility band of GBX 1,950 to GBX 2,070 over the next five trading days. Weekly indicators favor a rebound, with the baseline scenario showing sideways movement as oversold readings adjust. A move above the Kijun resistance near GBX 2,054 could target GBX 2,070, while a decisive break below GBX 2,000 may lead to a pullback toward GBX 1,950.

Viktoras Karapetjanc, Traders Union expert, sees near-term pressure in GSK but views the oversold signals as a chance for buyers to regroup. He notes current levels look attractive for those seeking value, especially with the price still held above the long-term trend. Karapetjanc believes macro and sentiment conditions favor stabilization as markets digest recent moves. "If GSK can reclaim the Kijun line above GBX 2,054, I expect a constructive reversal towards GBX 2,070," he says.

Earlier, analysts noted that GSK’s share price remained under short- and medium-term selling pressure but was supported by long-term technical strength amid ongoing buybacks. The latest readings of continued oversold conditions and weak trend suggest a potential inflection point, with traders monitoring for a shift should GSK decisively reclaim the Kijun resistance near GBX 2,054.

Source of Data: GSK Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.